HDAC9 and atherosclerosis: In the end, it plays a significant impact on the pathogenesis of atherosclerosis.237 In addition, trichostatin A, an HDAC inhibitor, blocks upregulation of uremia environment-induced markers of endothelial dysfunction (intercellular adhesion molecule-1, surface Toll-like receptor-4, von Wilebrand factor) and reactive oxygen species.